SHILPA MEDICARE LTD Q2 RESULTS
Fed rate cuts triumph over Trump’s economic policies: A defining market battle
The Federal Reserve's rate cuts are poised to shape the U.S. and global economies, potentially overshadowing the impact of Donald Trump's economic policies. Despite short-term market fluctuations, the Fed's focus on stability and addressing fiscal challenges is expected to have a more lasting influence on markets, including the USD/INR, EUR/USD, and GBP/USD.
Donald Trump's 10-point agenda if he wins US election 2024 revealed
Donald Trump has vowed that if he wins US election 2024, he will take some concrete and bold steps.
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 38%
What is different about the current volatility on the street – especially in the last 10 sessions – is that it has been limited to a part of the large-cap space. That too in select stocks with high FPI exposure. The probability of further selective correction cannot be ruled out given that the Q2 earning season has been kicked off by TCS. Stocks of companies that report better results and show improvements in their business operating matrix will weather the storm better. The selected stocks on our list depict a strong upward trajectory in their overall average score which is based on five key pillars – earnings, fundamentals, relative valuation, risk, and price momentum. This implies that there has been a significant improvement in their market outlook in the given time frame.
Stocks in news: DMart, Reliance Power, Bajaj Finance, Sundaram-Clayton, Bank of Baroda
M&M Financial is likely to be in focus as the company said it is expecting a 1% year-on-year decline in the overall disbursement in the second quarter.
Zomato captains India Inc’s dream Team XI with over 1,000% profit growth
The June quarter saw Zomato and 10 other companies achieving over 1,000% profit growth. Zomato's profit skyrocketed 12,550% year-on-year. Other remarkable performers were Shakti Pumps and Lotus Chocolate. Experts advise focusing on growth outlooks rather than past profits when making investment decisions.
Do Dr Lal Pathlabs' results indicate a turnaround for the sector? 4 stocks from diagnostic space, 3 with upside potential of up to 31%
Some sectors have a company which can be called as the bell weather of that sector and that is why its results of that company probably are indicative of what is happening in the sector. In case of the diagnostic, it is probably the Dr Lals path labs which would fit the criteria, it has national presence, large network, present in both physical and digital segment. So when the quarterly numbers come and they show improvement on many fronts then probably it is time to have a look at them more seriously and see if there is a possible turnaround building in the sector. This became even more important because these stocks had gained extremely high valuation and also popularity in terms of both retail and institutional participation. But then for close to two years, they have been a strong under performer in a strong bull market. Does this result mean that finally in terms of price war for customer acquisition over and now the valuation readjustment will start in the upward direction.
- Go To Page 1
Anand Rathi initiates coverage on 6 hospital stocks with upside potential of up to 25%
Anand Rathi initiates coverage on 6 hospital stocks, recommending 'buy' for Max Healthcare, Rainbow Children’s Medicare, KIMS, and Jupiter Life-Line Hospitals, while suggesting 'hold' for Global Health (MEDANTA) and Narayana Hrudayalaya. They cite India's healthcare market potential, driven by demographic changes and non-communicable diseases, forecasting 15% CAGR to Rs 7.7 lakh crore by FY25.
Akash Bhanshali picks stake in this multibagger, trims in 2 other smallcaps
Bhanshali has added Pan Electronics India into his kitty with purchase of a 2.50% stake in the January to March period. The stock has been in top form this year with over 70% returns so far. Over a one-year period the gains extend to 97%. This is significantly higher than the 26% returns given by Nifty in the same period.
Mamearth turns 7, Ghazal Alagh shares pitch deck from 2016 that Honasa sent to VCs for raising funds
The entrepreneur took to LinkedIn to inform her followers that the personal beauty care brand Mamaearth - a part of Honasa Consumer - turned a year older on Tuesday. She also shared a few points from the "first formal pitch deck."
Q2 Results on Friday: What to expect from M&M, Coal India, LIC and Hindalco
Among index majors, Coal India, Eicher Motors, Hindalco Industries, Mahindra & Mahindra, and Oil and Natural Gas Corp are set to release their quarterly numbers.
TCS Q1 results today: How investors should trade the stock; 6 major factors to watch
Tata Consultancy Services (TCS), which will release its earnings after market hours, is likely to put up a weak show for the June quarter, given the slowdown in technology spending and higher costs.
Screaming Buy! 400 midcap & smallcap stocks give double-digit returns in June
Indian equities, including the Nifty50 and Sensex, experienced gains for the fourth consecutive month in June. While the benchmark indices returned nearly 3% for the month, the midcap and smallcap segments were the top performers, with about 400 stocks delivering double-digit returns. Sectors such as automobiles, healthcare, and information technology saw strong buying interest, and experts recommend long-term investors to continue accumulating quality stocks while being cautious of profit booking. The upcoming Q1-FY24 results are expected to provide further fuel to the market rally.
Stocks in news: ZEE, Vodafone Idea, M&M, Info Edge, Samvardhana Motherson
Zee Entertainment Enterprises has reported a net loss of Rs 196 crore for the three months ended March period. Total income during the quarter under review fell 8% to Rs 1,934 crore.
Q4 Results: 23 companies whose profit may more than double
Kotak Institutional Equities expects banks under its coverage to report a 45% year-on-year (YoY) earnings growth while its forecast for IT services' quarter-on-quarter (QoQ) revenue growth ranges from a decline of 2.1% to a growth of 2.3% across its coverage universe.
Ahead of Market: 10 things that will decide D-Street action on Friday
A long bear candle was formed on the daily chart that engulfed the up move of the previous session. Technically, this pattern indicates lack of strength in the recent upside bounce and the weakness is likely to continue for the short term, said Nagaraj Shetti, Technical Research Analyst, HDFC Securities
Priyanka Chopra, Alia Bhatt, Shilpa Shetty and many other celebrities express grief over Turkey, Syria earthquake tragedy
Priyanka Chopra, Alia Bhatt, and Shilpa Shetty, among others, shared condolence notes in response to the earthquakes in Turkey and Syria.
Hot Stocks: Global brokerages on SAIL, Trent, Rainbow Children Medicare and Bharat Forge
"Standalone results are better than expected. Domestic and international businesses are well-placed for the next two years. Scale-up of non-auto business to aid in revenue and margin improvement," said the note.
Stocks in the news: LIC, Apollo Hospitals, Bata, Trent, Auro Pharma, Patym and Grasim
LIC, Grasim, ONGC, Info Edge, Divi's Labs, Hindustan Aeronautics, Hero Motocorp, Muthoot Finance, Astral, Power Finance Corp, Timken India, ZEE and Sun TV are among the companies that will announce their earnings for the quarter ended June 2022.
Daljeet Singh Kohli prefers bank to IT stocks now. Here’s why
“Right now we have a preference for banks. In IT, we have Infosys and Wipro in the long-term portfolios where we have a 3-5-year horizon. While we have increasing exposure in banks, we have been reducing it in IT for quite some time. We have moved out of midcap IT almost entirely except for one. Intellect is still there and among largecaps, Infosys and Wipro are there.”
Corporate Radar: Dividends, rights issues, AGMs and Q4 earnings
At least five stocks will go ex-dividend today. They included Angel One, Caplin Point Laboratories, Coforge, Cyient and Dolat Algotech.
Stocks in news: M&M, Divi's Labs, BoB, Fortis, Gulf Oil, Affle, Max Health
Here are some stocks which may buzz the most in today's trade.
The week that was in 10 stocks: TCI Express zooms 37%, Adani Green surges 19.5%
Most sectoral indices ended with gains wherein auto and banking were the top gainers. The broader markets too witnessed healthy buying interest as both midcap and smallcap ended higher by about 4 per cent.
Insurance and mutual fund monoliths to come out of India in next 10-20 years: Ajay Bagga
Insurance companies and mutual fund are going to double every few years, say the market expert
Shilpa Medicare gets tentative American health regulator nod for Apremilast tablets
The company has received tentative approval from US Food and Drug Administration for its abbreviated new drug application (ANDA) Apremilast tablets in the strengths of 10 mg, 20 mg, and 30 mg, Shilpa Medicare said in a regulatory filing.
After Hours: PSU banks lead the fall, IT sole gainer
RBI signalled a marginal rise in inflation for the current fiscal, which dragged the market lower.
Week 7: These 10 stocks surged up to 23% this week; Dr Reddy’s hit its fresh 52-week low
During the week, Tata Motors reported 96.20 per cent year-on-year fall in consolidated net profit at Rs 112 crore for the December quarter.
While offloading largecaps in Q3, FIIs fell in love with these 200 midcap & smallcap stocks
In the auto and auto ancillary space, foreign investors increased share holdings in Amara Raja Batteries, Sona Koyo Steering and Minda, Capitaline data showed.
Top 2 stock picks in pharma and IT: Daljeet Singh Kohli, IndiaNivesh
Among top tier companies, we are pushing on Lupin, Torrent among midcaps, Aurobindo and among smaller ones Shilpa Medicare and Ajanta Pharma
Mapping the market: 86 stocks at 52-wk highs, 216 hit upper circuits, investors pocket Rs 1,32,864 crore
28 of the 30 the benchmark Sensex stocks ended higher, while 86 BSE-listed stocks hit their 52-week highs and 216 others breached their upper circuit limits.
Load More
